Coya Tapia

3.5k total citations
47 papers, 2.3k citations indexed

About

Coya Tapia is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Coya Tapia has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 17 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Coya Tapia's work include HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (7 papers). Coya Tapia is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (7 papers). Coya Tapia collaborates with scholars based in Switzerland, United States and Germany. Coya Tapia's co-authors include Guido Sauter, Martina Mirlacher, Ronald Simon, Hedvika Novotny, Hanspeter Spichtin, Robert Maurer, Khawla S. Al‐Kuraya, Inti Zlobec, J. Torhorst and Spasenija Savic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Coya Tapia

46 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Coya Tapia Switzerland 28 1.1k 838 752 461 283 47 2.3k
Teijo Kuopio Finland 25 886 0.8× 791 0.9× 636 0.8× 264 0.6× 274 1.0× 119 2.2k
Yutaka Hatanaka Japan 27 1.2k 1.0× 712 0.8× 533 0.7× 653 1.4× 133 0.5× 143 2.2k
Marco Gerlinger United Kingdom 22 955 0.8× 1.1k 1.3× 1.2k 1.5× 647 1.4× 198 0.7× 62 2.4k
Véronique Becette France 18 1.0k 0.9× 889 1.1× 983 1.3× 412 0.9× 281 1.0× 56 2.2k
Kalliopi P. Siziopikou United States 25 1.0k 0.9× 1.0k 1.2× 888 1.2× 275 0.6× 149 0.5× 75 2.3k
Paul van Diest Netherlands 23 1.4k 1.3× 1.5k 1.8× 1.0k 1.4× 406 0.9× 275 1.0× 49 3.2k
Elena Guerini‐Rocco Italy 27 1.2k 1.0× 613 0.7× 716 1.0× 578 1.3× 143 0.5× 130 2.3k
Loren S. Michel United States 24 1.5k 1.3× 1.6k 1.9× 454 0.6× 441 1.0× 247 0.9× 72 2.9k
Vassiliki Kotoula Greece 27 1.2k 1.0× 1.2k 1.5× 539 0.7× 419 0.9× 118 0.4× 125 2.6k
S. Aaltomaa Finland 31 1.3k 1.2× 1.2k 1.5× 803 1.1× 754 1.6× 193 0.7× 93 3.0k

Countries citing papers authored by Coya Tapia

Since Specialization
Citations

This map shows the geographic impact of Coya Tapia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coya Tapia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coya Tapia more than expected).

Fields of papers citing papers by Coya Tapia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coya Tapia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coya Tapia. The network helps show where Coya Tapia may publish in the future.

Co-authorship network of co-authors of Coya Tapia

This figure shows the co-authorship network connecting the top 25 collaborators of Coya Tapia. A scholar is included among the top collaborators of Coya Tapia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coya Tapia. Coya Tapia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akçakanat, Argun, Scott Kopetz, Coya Tapia, et al.. (2022). Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Scientific Reports. 12(1). 1248–1248. 7 indexed citations
2.
Shariati, Maryam, Kurt W. Evans, Xiaofeng Zheng, et al.. (2021). Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 40(26). 4425–4439. 17 indexed citations
3.
Zhao, Ming, Erkan Yuca, Kurt W. Evans, et al.. (2021). First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Research. 23(1). 29–29. 48 indexed citations
4.
Imboden, Sara, Coya Tapia, Vida Kocbek, et al.. (2019). Early‐stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrence. Acta Obstetricia Et Gynecologica Scandinavica. 99(2). 196–203. 20 indexed citations
5.
Chakravarti, Deepavali, Christopher Terranova, Mayinuer Maitituoheti, et al.. (2019). Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor. Nature Communications. 10(1). 1398–1398. 44 indexed citations
6.
Habra, Mouhammed Amir, Bettzy Stephen, Matthew T. Campbell, et al.. (2019). Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 253–253. 108 indexed citations
7.
Keene, K.S., Tari A. King, E. Shelley Hwang, et al.. (2018). Molecular determinants of post-mastectomy breast cancer recurrence. npj Breast Cancer. 4(1). 34–34. 9 indexed citations
8.
Evans, Kurt W., Erkan Yuca, Argun Akçakanat, et al.. (2017). A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors. Clinical Cancer Research. 23(21). 6468–6477. 48 indexed citations
9.
Wu, Yun, Carlos A. Castañeda, Fei Yang, et al.. (2016). Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group. Annals of Surgical Oncology. 23(7). 2242–2248. 85 indexed citations
10.
Burckhardt, Marie‐Anne, Sameer S. Udhane, Nesa Marti, et al.. (2015). Human 3β-hydroxysteroid dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature. European Journal of Endocrinology. 173(5). K1–K12. 26 indexed citations
11.
Trippel, Mafalda, Katrin Pfaltz, Raoul A. Droeser, et al.. (2015). Androgen receptor status is highly conserved during tumor progression of breast cancer. BMC Cancer. 15(1). 872–872. 26 indexed citations
12.
Salhia, Bodour, Mafalda Trippel, Katrin Pfaltz, et al.. (2015). High tumor budding stratifies breast cancer with metastatic properties. Breast Cancer Research and Treatment. 150(2). 363–371. 67 indexed citations
13.
Čihorić, Nikola, et al.. (2014). IMRT with 18FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiation Oncology. 9(1). 83–83. 34 indexed citations
14.
Byron, Sara A., Elizabeth Min, Galen Hostetter, et al.. (2012). Negative Regulation of NF-κB by the ING4 Tumor Suppressor in Breast Cancer. PLoS ONE. 7(10). e46823–e46823. 38 indexed citations
15.
Droeser, Raoul A., Inti Zlobec, Ergin Kilic, et al.. (2012). Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer. 12(1). 134–134. 76 indexed citations
16.
Tapia, Coya, et al.. (2009). From Hyperkalemia to Ischemic Colitis: A Resinous Way. Clinical Gastroenterology and Hepatology. 7(8). e46–e47. 11 indexed citations
17.
Glatz‐Krieger, Katharina, Mona Pache, Coya Tapia, et al.. (2006). Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(3). 328–333. 29 indexed citations
18.
Al‐Kuraya, Khawla S., Hedvika Novotny, Prashant Bavi, et al.. (2006). HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. Journal of Clinical Pathology. 60(7). 768–772. 103 indexed citations
19.
Tornillo, Luigi, Vincenza Carafa, Alessandro Lugli, et al.. (2005). Patterns of gene amplification in gastrointestinal stromal tumors (GIST). Laboratory Investigation. 85(7). 921–931. 47 indexed citations
20.
Al‐Kuraya, Khawla S., Peter Schraml, J. Torhorst, et al.. (2004). Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer. Cancer Research. 64(23). 8534–8540. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teijo Kuopio Breakdown of academic impact, for papers by Yutaka Hatanaka Breakdown of academic impact, for papers by Marco Gerlinger Breakdown of academic impact, for papers by Véronique Becette Breakdown of academic impact, for papers by Kalliopi P. Siziopikou Breakdown of academic impact, for papers by Paul van Diest Breakdown of academic impact, for papers by Elena Guerini‐Rocco Breakdown of academic impact, for papers by Loren S. Michel Breakdown of academic impact, for papers by Vassiliki Kotoula Breakdown of academic impact, for papers by S. Aaltomaa
Rankless by CCL
2026